Holder of U.S. Patent Number: 10004757 Issued on June 26, 2018, and Trademark U.S. Serial Number 90843126 Issued on July 3, 2018. December 20, 2018:World Intellectual Property Organization (WIPO) Opinion of the International Search Authority: • Patent Claims Meet the Criterion for Industrial ApplicabilitySeeking buyer, partner, or licensee with a U.S.-based or global nutraceuticals manufacturer for the production, marketing, distribution, and sales of an oral, triple formula, nonprescription, dietary supplement designed to enhance cardiovascular health and cognitive skills.

Twenty years of acquired expertise in multimedia content development of clinical and scientific information and education initiatives, including peer-reviewed publications, which target healthcare practitioners and patients worldwide. Deliverables include but are not limited to: scientific platform development; publications planning; live events; congress activities, including satellite symposia; advisory boards; consensus panels and Delphi surveys; case-based, interactive learning programs; manuscript development and submission processes for publication in profesional journals; medical writer mentoring; client-facing interactions and collaborations with PRC teams; key opinion leaders, presenters, authors, congress officials, and peer-reviewers; new business development and organic account growth across a diversity of disease states and therapeutic categories such as: Oncology; Infectious Diseases; Cardiometabolic Diseases, including Diabetes Mellitus; Immunology; Chronic, Adult Respiratory Diseases; Neuropsychiatry.

Targeted Oncology● Developed relevant, accurate, high-quality, scientific and clinical deliverables including but not limited to digital, video, congress presentations and programs, live and virtual, interactive, case-based initiatives, which targeted the continuing information and education of academic and community oncologists and advanced practice providers. ●Applied relevant, contemporary, evidence-based medical literature, clinical practice guidelines, and data on evolving disease-state management, including novel therapies in clinical development, to content development across various, therapeutic areas in solid tumors oncology ●Generated interview and discussion guides, PowerPoint presentations, and other content for video, live, virtual, and online projects ●Supported, review and editing of filmed, segmented online programming.●Served as content expert at faculty reviews of scientific and clinical content; revised program materials as required through both internal and external review processes throughout the project lifecycle● Met timelines in advance of or on time for all scheduled deadlines, while maintaining superior accuracy and quality ●Effectively communicated and collaborated with colleagues in a cross-functional team with the shared goal of executing seamless, healthcare communications programs●Interfaced regularly in meetings with clients, advertisers, key opinion leaders, and faculty presenters to develop and sustain professional, collaborative relationships● Presented topics of interest at monthly department and peer-to-peer meetings● Developed an innovative concept for consolidated data analysis, integration, and dissemination of attendee responses to polling questions captured at the conclusion of each virtual and live Targeted Oncology event, with the goals of process improvement and an additional, value-added offering to industry partners.Special Therapeutic Focus: Oncology – Across the Full, Solid-Tumor Space